Trinity Biotech PLC (NASDAQ:TRIB) Set to Announce Quarterly Earnings on Thursday

Trinity Biotech PLC (NASDAQ:TRIB) is set to issue its quarterly earnings data on Thursday, July 20th. Analysts expect the company to announce earnings of $0.06 per share for the quarter.

Trinity Biotech PLC (NASDAQ:TRIB) last released its quarterly earnings results on Thursday, April 27th. The company reported $0.01 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.03 by $0.02. Trinity Biotech PLC had a negative net margin of 98.39% and a positive return on equity of 5.00%. The firm had revenue of $23.54 million for the quarter, compared to the consensus estimate of $24.24 million. On average, analysts expect Trinity Biotech PLC to post $0.27 EPS for the current fiscal year and $0.43 EPS for the next fiscal year.

Shares of Trinity Biotech PLC (NASDAQ:TRIB) opened at 5.73 on Tuesday. Trinity Biotech PLC has a 52-week low of $5.20 and a 52-week high of $13.68. The company’s 50 day moving average price is $5.70 and its 200 day moving average price is $6.05. The company’s market capitalization is $126.64 million.

COPYRIGHT VIOLATION WARNING: “Trinity Biotech PLC (NASDAQ:TRIB) Set to Announce Quarterly Earnings on Thursday” was published by Transcript Daily and is owned by of Transcript Daily. If you are reading this story on another site, it was illegally copied and republished in violation of U.S. & international trademark and copyright legislation. The correct version of this story can be viewed at https://transcriptdaily.com/2017/07/18/trinity-biotech-plc-nasdaqtrib-set-to-announce-quarterly-earnings-on-thursday.html.

TRIB has been the topic of several research analyst reports. Zacks Investment Research cut Trinity Biotech PLC from a “hold” rating to a “sell” rating in a research note on Wednesday, May 3rd. ValuEngine cut Trinity Biotech PLC from a “hold” rating to a “sell” rating in a research report on Friday, June 2nd.

Trinity Biotech PLC Company Profile

Trinity Biotech plc (Trinity Biotech) develops, acquires, manufactures and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market. The Company’s products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes, and disorders of the liver and intestine.

Earnings History for Trinity Biotech PLC (NASDAQ:TRIB)

Receive News & Ratings for Trinity Biotech PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trinity Biotech PLC and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply